![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 32, 24740-24751, August 11, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
¶,
,
,
, and
From the We have cloned a novel pancreatic beta cell and
neuroendocrine cell-specific calcium-binding protein termed
secretagogin. The cDNA obtained by immunoscreening a human
pancreatic cDNA library using the recently described murine
monoclonal antibody D24 contains an open reading frame of 828 base
pairs. This codes for a cytoplasmic protein with six putative EF finger
hand calcium-binding motifs. The gene could be localized to chromosome
6 by alignment with GenBank genomic sequence data. Northern blot
analysis demonstrated abundant expression of this protein in the
pancreas and to a lesser extent in the thyroid, adrenal medulla, and
cortex. In addition it was expressed in scant quantity in the
gastrointestinal tract (stomach, small intestine, and colon). Thyroid
tissue expression of secretagogin was restricted to C-cells. Using a
sandwich capture enzyme-linked immunosorbent assay with a detection
limit of 6.5 pg/ml, considerable amounts of constitutively secreted
protein could be measured in tissue culture supernatants of stably
transfected RIN-5F and dog insulinoma (INS-H1) cell clones; however, in
stably transfected Jurkat cells, the protein was only secreted upon CD3 stimulation. Functional analysis of transfected cell lines expressing secretagogin revealed an influence on calcium flux and cell
proliferation. In RIN-5F cells, the antiproliferative effect is
possibly due to secretagogin-triggered down-regulation of substance P transcription.
Department of Medicine III,
Department of Dermatology, and ** Department of Clinical
Pathology, University of Vienna, A-1090 Vienna, Austria and the

Infectious Disease Units, Pediatric and Medical
Services, Massachusetts General Hospital and Harvard Medical School,
Boston, Massachusetts 02129
The nucleotide sequence(s) reported in this paper has been submitted to GenBankTM/EBI Data Bank with the accession number(s) Y16752.
§ To whom correspondence should be addressed: Dept. of Medicine III, Div. of Clinical Endocrinology & Metabolism, University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. Fax: 43-1-40400/7790; E-mail: ludwig.wagner@akh-wien.ac.at. ¶ Recipient of a scholarship from the Austrian Academy of Science.This article has been cited by other articles:
![]() |
W. Gartner, G. Vila, T. Daneva, A. Nabokikh, F. Koc-Saral, A. Ilhan, O. Majdic, A. Luger, and L. Wagner New functional aspects of the neuroendocrine marker secretagogin based on the characterization of its rat homolog Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E347 - E354. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Palczewska, G. Batta, P. Groves, S. Linse, and J. Kuznicki Characterization of calretinin I-II as an EF-hand, Ca2+, H+-sensing domain Protein Sci., July 1, 2005; 14(7): 1879 - 1887. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Palczewska, P. Groves, G. Batta, B. Heise, and J. Kuznicki Calretinin and calbindin D28k have different domain organizations Protein Sci., January 1, 2003; 12(1): 180 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Berggard, O. Szczepankiewicz, E. Thulin, and S. Linse myo-Inositol Monophosphatase Is an Activated Target of Calbindin D28k J. Biol. Chem., October 25, 2002; 277(44): 41954 - 41959. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Gartner, W. Lang, F. Leutmetzer, H. Domanovits, W. Waldhausl, and L. Wagner Cerebral Expression and Serum Detectability of Secretagogin, a Recently Cloned EF-hand Ca2+ -binding Protein Cereb Cortex, December 1, 2001; 11(12): 1161 - 1169. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |